Literature DB >> 9603157

Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.

L G van 't Hek1, P E Verweij, C M Weemaes, R van Dalen, J B Yntema, J F Meis.   

Abstract

A 5-year-old boy with chronic granulomatous disease (CGD) was treated with amphotericin B for an invasive pulmonary Aspergillus nidulans infection. The infection progressed during 6 wk of treatment despite the addition of interferon-gamma (IFN-gamma), filgrastim, and transfusions with donor granulocytes. Treatment with a novel antifungal triazole, voriconazole, resulted in an excellent clinical response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603157     DOI: 10.1164/ajrccm.157.5.9709068

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

Review 1.  Voriconazole: in the treatment of invasive aspergillosis.

Authors:  Richard B R Muijsers; Karen L Goa; Lesley J Scott
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens.

Authors:  Jan W M van der Linden; Eveline Snelders; Jan P Arends; Simon M Daenen; Willem J G Melchers; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

3.  A review of clinical experience with newer antifungals in children.

Authors:  Renee M Fallon; Jennifer E Girotto
Journal:  J Pediatr Pharmacol Ther       Date:  2008-07

4.  Validated LC Method for the Estimation of Voriconazole in Bulk and Formulation.

Authors:  C N Patel; J B Dave; J V Patel; B Panigrahi
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

5.  Spontaneous empyema necessitatis caused by Aspergillus fumigatus in an immunocompetent patient.

Authors:  Chih-Hao Chen; Hung-Chang Liu; Tsing-Tshih Tsung; Tzu-Ti Hung
Journal:  JRSM Short Rep       Date:  2011-03-31

6.  Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.

Authors:  H Sambatakou; M Guiver; D Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-18       Impact factor: 3.267

Review 7.  Invasive aspergillosis caused by Aspergillus ustus: case report and review.

Authors:  P E Verweij; M F van den Bergh; P M Rath; B E de Pauw; A Voss; J F Meis
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 8.  Fungal infections in primary immunodeficiencies.

Authors:  Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2007-06-06       Impact factor: 3.183

9.  Successful treatment of fungal osteomyelitis with voriconazole in a patient with chronic granulomatous disease.

Authors:  Masoud Mohammadpour; Setareh Mamishi; Mahsa Oaji; Zahra Pourpak; Nima Parvaneh
Journal:  Iran J Pediatr       Date:  2010-12       Impact factor: 0.364

Review 10.  In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors:  A Espinel-Ingroff; K Boyle; D J Sheehan
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.